The Latest Breaking News from HUM

While Humana has notably underperformed the broader healthcare sector over the past year, it has outperformed recently, and analysts remain optimistic about the stock’s prospects.

While Humana stock seems to be regaining momentum lately, it is still underperforming the broader market, keeping analysts cautiously optimistic about its prospects.

As the healthcare landscape evolves with new legislation and shifting demographics, Humana Inc. (NYSE:HUM) is adapting to these changes through strategic adjustments. This adaptability is reflected in their second-quarter earnings report, which exceeded analysts’ expectations despite a decline in adjusted EPS compared to last year.

Humana Inc. NYSE: HUM) on Tuesday announced accelerated efforts to approve care requests as quickly as possible and reduce the administrative burden for physicians associated with prior authorization.

Shares of Humana Inc. (NYSE:HUM) are trading lower Friday after the company lost a legal battle over Medicare bonus payments.

Humana Inc. (NYSE:HUM) is consolidating on Wednesday. But it may be about to reverse and rally.

Humana has underperformed the Dow over the past year, but analysts are moderately optimistic about the stock’s prospects.

Humana has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

What we know about The Resistance Front, Lashkar-e-Taiba, Jaish-e-Muhammad and Hizb-ul-Mujahideen.

India struck multiple targets in Pakistan and Pakistan-administered Kashmir in the aftermath of the Pahalgam attack.

Humana is expected to release its fiscal first-quarter earnings later this month, and analysts project a double-digit profit rise.